Balance Sheet

Current Liabilities	42.4m
Accounts Payable	5m
Accrued Liabilities	25.9m
Other Current Liabilities	11.5m
Non-Current Liabilities	30m
Long-Term Debt	27.2m
Other Non-Current Liabilities	2.8m

Currency: USD

	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021
Assets
Cash & Cash Equivalents	76	51	52	27	15	15	24	30	62	71
Cash Equivalents	76	51	52	27	15	15	24	30	62	71
Short-Term Investments	85	68	0	8	8	19	0	18	0	17
Total Receivables	24	7	2	5	1	15	3	2	1	12
Accounts Receivables	21	1	2	5	1	0	3	2	1	12
Other Receivables	3	6	0	0	0	15	0	0	0	0
Inventory	0	0	0	0	0	0	0	0	0	2
Other Current Assets	6	4	5	2	2	1	1	1	3	4
Total Current Assets	191	129	59	40	26	50	28	51	66	105
PP&E Net	13	14	11	0	0	0	0	0	1	0
PP&E Gross	13	14	11	0	0	0	0	0	0	0
Accumulated Depreciation	13	15	16	0	0	0	0	0	0	0
Other Long-Term Assets	4	3	0	0	1	0	0	0	0	0
Total Assets	208 N/A	146 -29%	71 -52%	41 -43%	27 -33%	50 +84%	28 -44%	51 +81%	67 +32%	105 +57%
Liabilities
Accounts Payable	11	4	3	1	2	2	4	2	3	3
Accrued Liabilities	20	13	9	4	6	11	9	8	9	15
Short-Term Debt	0	0	0	0	0	0	0	0	0	0
Current Portion of Long-Term Debt	7	10	12	2	2	0	3	10	1	0
Other Current Liabilities	2	4	16	5	1	19	2	2	3	1
Total Current Liabilities	39	31	40	12	10	32	18	21	17	19
Long-Term Debt	19	9	9	7	12	19	16	6	13	38
Other Liabilities	30	36	1	4	7	40	21	8	2	3
Total Liabilities	89 N/A	76 -14%	50 -34%	23 -53%	29 +25%	91 +212%	55 -39%	36 -35%	32 -12%	59 +88%
Equity
Common Stock	0	0	0	0	0	0	0	0	0	0
Retained Earnings	320	427	480	495	522	587	595	586	621	675
Additional Paid In Capital	439	497	501	512	520	546	568	600	657	720
Other Equity	0	0	0	0	0	0	0	0	0	0
Total Equity	119 N/A	70 -41%	21 -71%	17 -17%	2 N/A	41 -2 047%	27 +33%	15 N/A	35 +139%	46 +30%
Total Liabilities & Equity	208 N/A	146 -29%	71 -52%	41 -43%	27 -33%	50 +84%	28 -44%	51 +81%	67 +32%	105 +57%
Shares Outstanding
Common Shares Outstanding	4	5	5	6	8	12	13	16	27	34

Aveo Pharmaceuticals Inc
NASDAQ:AVEO